Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | PTPRB | P23467 | 2/20 | 0.34 |
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8945799 | 0.85 | YTHDC1 (0.33) | LTA4HCYP2C19SLC6A3 | |
| SCHEMBL21914932 | 0.80 | PTPRB (0.47) | PTPRBCYP2C19SLC6A3 | |
| SCHEMBL8946109 | 0.77 | YTHDC1 (0.32) | HDAC1 | |
| SCHEMBL8945988 | 0.75 | YTHDC1 (0.33) | PTPRBLTA4HCYP2C19SLC6A3 | |
| SCHEMBL8945955 | 0.74 | TSHR (0.38) | SLC6A3TSHR | |
| SCHEMBL8946115 | 0.74 | SLC6A2 (0.31) | SLC6A3 | |
| SCHEMBL8945855 | 0.73 | HDAC1 (0.35) | HDAC1HDAC2SLC6A3 | |
| SCHEMBL8945781 | 0.72 | — | — | |
| SCHEMBL8946074 | 0.72 | AR (0.34) | — | |
| SCHEMBL8945940 | 0.72 | KDM4E (0.31) | LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5510346-A | ANTIDEPRESSANTS, ANTIANXIETY AGENTS | HOECHST MARION ROUSSEL, INC. (US) | 1996-04-23 | — | — | US | disclosed |
| US-5292760-A | 4-heteroaryl-1,3-benzodiazepines and 2-substituted-α-(heteroaryl)benzeneethanamines | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1994-03-08 | — | — | US | disclosed |
| EP-0322582-A2 | 4-Heteroaryl-1,3-Benzodiazepines and 2-substituted-alpha-(heteroaryl)benzeneethanamines, a process for their preparation and their use us medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1989-07-05 | — | — | EP | disclosed |